| 000 | 01108 a2200289 4500 | ||
|---|---|---|---|
| 005 | 20250511232502.0 | ||
| 264 | 0 | _c19910306 | |
| 008 | 199103s 0 0 eng d | ||
| 022 | _a0190-9622 | ||
| 024 | 7 |
_a10.1016/0190-9622(90)70354-k _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMockli, G | |
| 245 | 0 | 0 |
_aLaboratory monitoring of cyclosporine levels: guidelines for the dermatologist. _h[electronic resource] |
| 260 |
_bJournal of the American Academy of Dermatology _cDec 1990 |
||
| 300 |
_a1275-8; discussion 1278-9 p. _bdigital |
||
| 500 | _aPublication Type: Guideline; Journal Article | ||
| 650 | 0 | 4 |
_aBlood Specimen Collection _xmethods |
| 650 | 0 | 4 | _aChromatography, High Pressure Liquid |
| 650 | 0 | 4 |
_aCyclosporins _xadverse effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImmunoassay |
| 650 | 0 | 4 |
_aSkin Diseases _xblood |
| 700 | 1 | _aKabra, P M | |
| 700 | 1 | _aKurtz, T W | |
| 773 | 0 |
_tJournal of the American Academy of Dermatology _gvol. 23 _gno. 6 Pt 2 _gp. 1275-8; discussion 1278-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/0190-9622(90)70354-k _zAvailable from publisher's website |
| 999 |
_c2283214 _d2283214 |
||